Victory Capital Management Inc. Buys 844,426 Shares of Hologic, Inc. (HOLX)
Victory Capital Management Inc. grew its stake in shares of Hologic, Inc. (NASDAQ:HOLX) by 16.8% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 5,856,778 shares of the medical equipment provider’s stock after acquiring an additional 844,426 shares during the period. Hologic accounts for approximately 0.5% of Victory Capital Management Inc.’s portfolio, making the stock its 18th largest holding. Victory Capital Management Inc. owned 2.09% of Hologic worth $214,885,000 as of its most recent SEC filing.
Several other large investors also recently bought and sold shares of HOLX. Teachers Advisors LLC lifted its position in shares of Hologic by 36.4% during the first quarter. Teachers Advisors LLC now owns 877,549 shares of the medical equipment provider’s stock worth $37,340,000 after acquiring an additional 234,002 shares in the last quarter. Janus Capital Management LLC lifted its position in shares of Hologic by 21.5% during the first quarter. Janus Capital Management LLC now owns 422,423 shares of the medical equipment provider’s stock worth $17,974,000 after acquiring an additional 74,650 shares in the last quarter. Nomura Asset Management Co. Ltd. lifted its position in shares of Hologic by 8.2% during the first quarter. Nomura Asset Management Co. Ltd. now owns 35,498 shares of the medical equipment provider’s stock worth $1,510,000 after acquiring an additional 2,700 shares in the last quarter. DnB Asset Management AS lifted its position in shares of Hologic by 42.6% during the second quarter. DnB Asset Management AS now owns 27,805 shares of the medical equipment provider’s stock worth $1,262,000 after acquiring an additional 8,300 shares in the last quarter. Finally, Xact Kapitalforvaltning AB lifted its position in shares of Hologic by 9.9% during the second quarter. Xact Kapitalforvaltning AB now owns 63,419 shares of the medical equipment provider’s stock worth $2,878,000 after acquiring an additional 5,735 shares in the last quarter. Hedge funds and other institutional investors own 95.68% of the company’s stock.
TRADEMARK VIOLATION NOTICE: “Victory Capital Management Inc. Buys 844,426 Shares of Hologic, Inc. (HOLX)” was published by TheOlympiaReport and is owned by of TheOlympiaReport. If you are viewing this story on another website, it was illegally copied and republished in violation of US & international copyright and trademark laws. The original version of this story can be read at https://theolympiareport.com/2017/10/31/victory-capital-management-inc-buys-844426-shares-of-hologic-inc-holx.html.
Several equities research analysts have issued reports on the company. Barclays PLC restated an “overweight” rating and set a $53.00 target price (up previously from $50.00) on shares of Hologic in a research report on Monday, July 17th. Zacks Investment Research downgraded Hologic from a “hold” rating to a “sell” rating in a research report on Tuesday, October 3rd. BidaskClub downgraded Hologic from a “buy” rating to a “hold” rating in a research report on Wednesday, August 2nd. Stifel Nicolaus restated a “buy” rating on shares of Hologic in a research report on Friday, July 14th. Finally, Bank of America Corporation restated a “neutral” rating and set a $48.00 target price (up previously from $44.00) on shares of Hologic in a research report on Friday, July 21st. Two investment analysts have rated the stock with a sell rating, four have given a hold rating and nine have given a buy rating to the company’s stock. Hologic has an average rating of “Hold” and a consensus price target of $47.77.
In other Hologic news, Director Elaine Ullian sold 6,902 shares of the business’s stock in a transaction on Thursday, August 3rd. The shares were sold at an average price of $40.12, for a total value of $276,908.24. Following the sale, the director now owns 23,810 shares in the company, valued at approximately $955,257.20. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Lawrence M. Levy sold 9,596 shares of the business’s stock in a transaction on Tuesday, October 10th. The stock was sold at an average price of $36.81, for a total transaction of $353,228.76. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 30,775 shares of company stock worth $1,175,662. 0.79% of the stock is owned by corporate insiders.
Shares of Hologic, Inc. (HOLX) traded down 0.05% during midday trading on Tuesday, hitting $37.19. The company had a trading volume of 541,525 shares. The stock has a 50 day moving average price of $37.23 and a 200 day moving average price of $41.44. Hologic, Inc. has a 1-year low of $35.15 and a 1-year high of $46.80. The firm has a market capitalization of $10.43 billion, a P/E ratio of 13.85 and a beta of 0.91.
Hologic (NASDAQ:HOLX) last released its earnings results on Wednesday, August 2nd. The medical equipment provider reported $0.50 earnings per share for the quarter, beating analysts’ consensus estimates of $0.49 by $0.01. Hologic had a net margin of 25.65% and a return on equity of 23.18%. The company had revenue of $806.10 million for the quarter, compared to analysts’ expectations of $799.70 million. During the same quarter in the previous year, the company earned $0.51 EPS. Hologic’s revenue for the quarter was up 12.4% on a year-over-year basis. On average, equities analysts anticipate that Hologic, Inc. will post $2.01 EPS for the current fiscal year.
Hologic Company Profile
Hologic, Inc is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products with an emphasis on women’s health. The Company operates through four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The diagnostics products include Aptima family of assays, ThinPrep system, the Rapid Fetal Fibronectin Test and Procleix blood screening assays.
Want to see what other hedge funds are holding HOLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hologic, Inc. (NASDAQ:HOLX).
Receive News & Ratings for Hologic Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hologic Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.